National registry for fecal microbiota transplantation

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study establishes a national data registry for patients undergoing fecal microbiota transplantation (FMT) and other gut-related microbiota products. It aims to prospectively evaluate the short and long-term safety and effectiveness of these treatments by collecting data from patient and donor medical records, as well as research records. The study will not enroll neonates and will focus on individuals who can provide informed consent and have access to communication tools. Data will be gathered from various sources, including patient visits and phone calls.

Why it matters

Who can join: the full rules

Recipient Inclusion Criteria :

* Ability to give informed consent
* Receiving FMT or other gut-related microbiota product within 90 days after providing consent
* Access to internet and/or telephone

Donor Inclusion Criteria:

* Ability to give informed consent
* Providing stool sample for FMT

Exclusion Criteria:

* Incarceration

Where it's running

• University of California, San Francisco
  San Francisco, California, United States Recruiting

Study contacts

• Principal investigator: Max Brondfield, MD — University of California, San Francisco
• Study coordinator: Rachael Leigh Delacruz
• Email: rachaelleigh.delacruz@ucsf.edu
• Phone: 4155148087

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Fecal transplant plus standard therapy for refractory hepatic encephalopathy after TIPS

  This study tests whether adding fecal microbiota transplantation to usual medicines helps people with recurrent hepatic encephalopathy after TIPS implant.

  Recruiting Early Phase 1 Air Force Military Medical University, China · Xi'an · NCT07683936

• Using fecal microbiota transplantation to prevent infections after liver transplantation

  This study is testing if a special treatment using healthy stool can help prevent infections in people getting a liver transplant.

  Recruiting IRCCS Azienda Ospedaliero-Universitaria di Bologna · Bologna · NCT06782880

• Maternal fecal transplant for babies born by cesarean section

  This trial will try giving a small fecal transplant from the mother to newborns delivered by elective C-section to see if it improves their gut microbiome and lowers the risk of later overweight or obesity.

  Recruiting Oulu University Hospital · Oulu · NCT06282952

• Using fecal microbiota transplantation to reduce colorectal adenoma recurrence

  This study tests if a treatment using healthy gut bacteria can help prevent the return of colorectal adenomas in patients who have had them removed.

  Recruiting Phase 2 Shenzhen Hospital of Southern Medical University · Guangzhou, Guangdong and 4 other locations · NCT06205862

• Using fecal transplantation to eliminate drug-resistant bacteria

  This study is testing whether using fecal transplants can help adults get rid of harmful drug-resistant bacteria in their gut.

  Recruiting Phase 3 Assistance Publique - Hôpitaux de Paris · Clichy and 10 other locations · NCT05035342

• Restoring gut bacteria in patients with Crohn's disease

  This study is testing whether a treatment using healthy gut bacteria can help people with active Crohn's disease feel better.

  Recruiting Phase 1/2 St Vincent's Hospital Melbourne · Melbourne, Victoria · NCT04970446

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.